Echo Therapeutics Inc fka ECTE

[ramad]

Ramad is astonished how ignorent of many of the recent postings. Fact, as filed by By echo to the SEC. The noteholders ascertain the rights to echo's technology, patents ecte. When echo defaults on the note. Plain and simple. IF echo gets outside funding the new funders would have to pony up in excess of $5M to buy them out or the noteholders still control the assets and could go to court claiming they are in default. What cmpany would make such an investment plus millions to develop the CGM. I believe alan being he has such a large stake approached some of the major companies and with the billions they invest in mergers and acquisitions he currently came up blank. That alone must send a signal. What's $10 to $20M to invest.

One of the posters asked what good is the technology without echo. The noteholders could form an alliance with a major company to further develop on echo's technology or the noteholders can pony up one for an outside vendor to develop.Echo's golden egg is their technology and patterns which they reported they could loose. The wild card is apple if Alan got in touch with them to inform them of echo technology if it will enhance apples technology to their CGM they want to develop.
If Ramad was advising Alan Ramad would have him get on a plane with all the technology and patents as well as many of the new components of the CGM and ask for a 15 minute presentation. Leave it all on the table. He should do the same with any large company that he feels might be interested. Their not going to come to him.It might cost him a few thousand but it's worth trying and he has nothing to loose. to save his 750,000 shares to have a value.